Replies to post #10345 on Innovus Pharmaceuticals Inc. (fka INNV)

[jtaylor68]

Thanks. I was particularly interested in your take on Dr. Damajs time as CEO at APRI. I know how you think about his performance at INNV.

The APRI angle is important in so far as a few posters, in particular twistedfreak tend to make bold and IMO unjustified claims about his past at APRI. This goes as far as waging a war of egos I think.
Based on my own research, he has been quite an accomplished businessman and also his tenure as CEO of APRI hasn't been plagued by failures. Quite to the contrary, from what I read so far I find he has made more of APRI than the company ever was before.

I just want to make sure that no false rumors are being spread about Dr. Damaj. If you can prove otherwise, I will listen.

[BooDog]

When Q4 is in black and white I think we may be able to start kicking back and watch this grow. Still adding product which takes off on the bottom line till they start bringing in revs. So again I say, cash positive in 2018. But this summer and through the rest of 2017, a steady growth.

Imo